BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 17646210)

  • 1. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
    Mazzucotelli A; Viguerie N; Tiraby C; Annicotte JS; Mairal A; Klimcakova E; Lepin E; Delmar P; Dejean S; Tavernier G; Lefort C; Hidalgo J; Pineau T; Fajas L; Clément K; Langin D
    Diabetes; 2007 Oct; 56(10):2467-75. PubMed ID: 17646210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiac development of the rat.
    Steinmetz M; Quentin T; Poppe A; Paul T; Jux C
    Basic Res Cardiol; 2005 May; 100(3):263-9. PubMed ID: 15754086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted disruption of glycerol kinase gene in mice: expression analysis in liver shows alterations in network partners related to glycerol kinase activity.
    MacLennan NK; Rahib L; Shin C; Fang Z; Horvath S; Dean J; Liao JC; McCabe ER; Dipple KM
    Hum Mol Genet; 2006 Feb; 15(3):405-15. PubMed ID: 16368706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro screening of 200 pesticides for agonistic activity via mouse peroxisome proliferator-activated receptor (PPAR)alpha and PPARgamma and quantitative analysis of in vivo induction pathway.
    Takeuchi S; Matsuda T; Kobayashi S; Takahashi T; Kojima H
    Toxicol Appl Pharmacol; 2006 Dec; 217(3):235-44. PubMed ID: 17084873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes.
    Guan HP; Ishizuka T; Chui PC; Lehrke M; Lazar MA
    Genes Dev; 2005 Feb; 19(4):453-61. PubMed ID: 15681609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of promethin and PGLP as two novel up-regulated genes in PPARgamma1-induced adipogenic mouse liver.
    Yu S; Viswakarma N; Batra SK; Sambasiva Rao M; Reddy JK
    Biochimie; 2004 Nov; 86(11):743-61. PubMed ID: 15589683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
    Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-alpha and -gamma.
    Nie W; Sweetser S; Rinella M; Green RM
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G207-12. PubMed ID: 15458920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of novel and selective peroxisome proliferator-activated receptor alpha agonists with robust hypolipidemic activity in vivo.
    Kane CD; Stevens KA; Fischer JE; Haghpassand M; Royer LJ; Aldinger C; Landschulz KT; Zagouras P; Bagley SW; Hada W; Dullea R; Hayward CM; Francone OL
    Mol Pharmacol; 2009 Feb; 75(2):296-306. PubMed ID: 18971326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The G0/G1 switch gene 2 is a novel PPAR target gene.
    Zandbergen F; Mandard S; Escher P; Tan NS; Patsouris D; Jatkoe T; Rojas-Caro S; Madore S; Wahli W; Tafuri S; Müller M; Kersten S
    Biochem J; 2005 Dec; 392(Pt 2):313-24. PubMed ID: 16086669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
    Lapinskas PJ; Brown S; Leesnitzer LM; Blanchard S; Swanson C; Cattley RC; Corton JC
    Toxicology; 2005 Feb; 207(1):149-63. PubMed ID: 15590130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands.
    Rival Y; Stennevin A; Puech L; Rouquette A; Cathala C; Lestienne F; Dupont-Passelaigue E; Patoiseau JF; Wurch T; Junquéro D
    J Pharmacol Exp Ther; 2004 Nov; 311(2):467-75. PubMed ID: 15273253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor alpha deficiency modifies glucose handling by isolated mouse adipocytes.
    Walker CG; Sugden MC; Gibbons GF; Holness MJ
    J Endocrinol; 2007 Apr; 193(1):39-43. PubMed ID: 17400801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.
    Han KL; Choi JS; Lee JY; Song J; Joe MK; Jung MH; Hwang JK
    Diabetes; 2008 Mar; 57(3):737-45. PubMed ID: 18065517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor α (PPARα) induces PPARγ coactivator 1α (PGC-1α) gene expression and contributes to thermogenic activation of brown fat: involvement of PRDM16.
    Hondares E; Rosell M; Díaz-Delfín J; Olmos Y; Monsalve M; Iglesias R; Villarroya F; Giralt M
    J Biol Chem; 2011 Dec; 286(50):43112-22. PubMed ID: 22033933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue.
    Rosell M; Hondares E; Iwamoto S; Gonzalez FJ; Wabitsch M; Staels B; Olmos Y; Monsalve M; Giralt M; Iglesias R; Villarroya F
    Endocrinology; 2012 Mar; 153(3):1162-73. PubMed ID: 22253419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.
    Xu C; Wang LL; Liu HY; Zhou XB; Cao YL; Li S
    Acta Pharmacol Sin; 2006 Feb; 27(2):223-8. PubMed ID: 16412273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for differential effects of glucose and cycloheximide on mRNA levels of peroxisome proliferator-activated receptor- (PPAR-) machinery members: Superinduction of PPAR-gamma1 and -gamma2 mRNAs.
    Rypka M; Veselý J
    Acta Biochim Pol; 2010; 57(2):209-15. PubMed ID: 20563322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
    Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
    Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.